ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,562Medicare Part D Prescriptions Filled, Including Refills

Rank: 127 out of 2094

$735K Total Retail Price of All Prescriptions

Rank: 216 out of 2094

443 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 443 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

10% of this provider’s 443 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

0% of this provider’s 10,159 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
OMEPRAZOLE 414 378 1 4
LEVOTHYROXINE SODIUM 413 379 2 3
AMLODIPINE BESYLATE 399 363 3 2
FUROSEMIDE 379 327 4 6
SIMVASTATIN 339 311 5 1
METOPROLOL TARTRATE 324 282 6 10
DONEPEZIL HCL 284 284 7 20
NAMENDA 254 254 8 32
WARFARIN SODIUM 245 237 9 11
LISINOPRIL 216 175 10 7
METFORMIN HCL 197 162 11 8
PRAVASTATIN SODIUM 190 140 12 18
TRAMADOL HCL 181 139 13 33
POTASSIUM CHLORIDE 177 167 14 24
CLOPIDOGREL 146 125 15 22
ZOLPIDEM TARTRATE 129 79 16 14
RISPERIDONE 129 113 16 56
CITALOPRAM HBR 126 108 18 47
METOPROLOL SUCCINATE 126 118 18 9
ATORVASTATIN CALCIUM 123 100 20 5
HYDROCODONE-ACETAMINOPHEN 122 96 S3 21 42
FAMOTIDINE 122 100 21 34
TRAZODONE HCL 117 91 23 72
SERTRALINE HCL 115 108 24 26
GABAPENTIN 114 87 25 23
MIRTAZAPINE 105 105 26 43
FENTANYL 101 56 S2 27 68
KLOR-CON M20 98 98 28 106
POLYETHYLENE GLYCOL 3350 97 97 29 75
ALLOPURINOL 95 92 30 50
ISOSORBIDE MONONITRATE ER 91 91 31 57
CARVEDILOL 88 85 32 19
PLAVIX 87 72 33 38
PANTOPRAZOLE SODIUM 84 76 34 37
FLUTICASONE PROPIONATE 82 70 35 41
ADVAIR DISKUS 81 76 36 36
CYMBALTA 79 73 37 61
LIDODERM 74 70 38 59
LEVETIRACETAM 72 72 39 78
TAMSULOSIN HCL 72 63 39 29
OXYCODONE-ACETAMINOPHEN 67 39 S2 41 40
SINGULAIR 67 62 41 64
PREDNISONE 66 63 43 54
LOSARTAN POTASSIUM 66 51 43 17
HYDROCHLOROTHIAZIDE 65 64 45 12
DILTIAZEM 24HR CD 63 63 46 110
PAROXETINE HCL 61 51 47 77
FINASTERIDE 59 59 48 97
BUSPIRONE HCL 57 57 49 159
CARBIDOPA-LEVODOPA 57 57 49 102
GLIPIZIDE ER 56 47 51 126
ATENOLOL 56 49 51 21
DIOVAN 56 56 51 13
ESCITALOPRAM OXALATE 54 47 54 46
HYDRALAZINE HCL 52 51 55 89
OXYBUTYNIN CHLORIDE ER 52 45 55 138
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 10, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.